Colgate Q2 Earnings Beat Estimates on Strong Margins, Sales Rise 4.9%

The company maintained a 41.3% year-to-date share of the global toothpaste market. It also held a 32.7% share of the worldwide manual toothbrush market. These leadership positions support management's strategy of investing in innovation and brand-building initiatives. Colgate expects strong investment levels to continue through the remainder of 2026.

Hill's Pet Nutrition net sales rose 3.4%, while organic sales increased 2.1%. Pricing improved 3.9%, but organic volume declined 1.8%, partly reflecting the company's exit from private-label pet food.

This Zacks Rank #3 (Hold) company’s shares have gained 4.9% in the past three months compared with the industry’s 2.1% growth.

CL's Margin Gains Offset Cost Pressures

GAAP and Base Business gross profit margin expanded 140 basis points year over year to 61.5%. The improvement strengthened profitability despite a difficult operating environment and continued spending behind brands.

Base Business operating profit increased 5% to $1.1 billion. The adjusted operating margin edged up 10 basis points to 21.4%, showing that stronger gross margin performance and productivity actions helped absorb higher investments.

Base Business selling, general and administrative expenses were $2.1 billion, while the adjusted expense rate increased 120 basis points to 39.6% of sales. We had expected selling, general and administrative expenses to increase 30 basis points to 38.7% of sales.

Advertising spending climbed 15% to $777 million from $678 million a year ago. Management said elevated investment will continue in the back half as the company focuses on premium, science-led innovation and omnichannel demand generation.

CL's Regional Sales Picture Stays Mixed

North America net sales fell 3% and organic sales also declined 3%, reflecting a 3.9% drop in volume that more than offset 0.9% pricing growth. The region accounted for 17% of total company sales.

Latin America remained the strongest growth contributor, with net sales up 13.7% and organic sales rising 5.3%. Volume grew 2.6%, pricing increased 2.8% and foreign exchange contributed 8.4%.

Europe, Middle East & Africa net sales increased 3.5%, while organic sales rose 2%. A 3.2% volume gain more than offset a 1.2% pricing decline, and currency added 1.6%.

Asia Pacific net sales advanced 4.9% and organic sales grew 5.2%, driven by 4.1% volume growth and 1.1% pricing. Foreign exchange reduced the region's reported sales growth by 0.3%.

Our model had expected sales to decline 0.9% year over year in North America, rise 7% in Latin America, jump 6.1% in Europe, Middle East & Africa and rise 7% in Asia Pacific.

CL Strengthens Cash Flow and Liquidity

Net cash provided by operations reached $1.7 billion in the first six months of 2026, up from $1.5 billion a year ago. Free cash flow before dividends increased to $1.5 billion from $1.3 billion.

CL ended June with $1.4 billion in cash and cash equivalents and total debt of $7.9 billion. During the first half, the company paid $879 million in dividends and purchased $597 million of treasury shares.

Colgate Updates 2026 Profitability Outlook

Colgate maintained its 2026 net sales growth outlook of 2-6% and organic sales growth guidance of 1-4%. Foreign exchange is still expected to provide a low-single-digit positive impact at current spot rates.

Management now expects both GAAP and Base Business gross profit margin to be roughly flat year over year, improving from its prior expectation of a decline. It also raised its Base Business earnings growth forecast to mid-single digits from low- to mid-single-digit growth, while retaining its view for double-digit GAAP earnings growth.

Stocks to Consider in the Consumer Staples Space 

United Natural Foods UNFI, which is the leading distributor of natural, organic and specialty food and non-food products, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. 

The Zacks Consensus Estimate for United Natural Foods’ current financial-year sales indicates a drop of 2.1% from the prior-year level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank #2 (Buy). MED missed the average earnings surprise by a sharp margin in the trailing four quarters. 

The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 25.9% from the year-ago number. 

Freshpet, Inc. FRPT, which manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats, currently carries a Zacks Rank of 2. 

The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 9.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 49.4%, on average.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research